Central Alerting System
View Alert


Originator: MHRA Drug Alerts

From: Sze Mun Tan

Issue date: 07-Sep-2020 09:59:22

This alert has been issued to:
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director

  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Chief Executive
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive
  • GP - Locum
  • NHS 111 and Out of hours providers
  • Dispensing GP Practices
  • DHSC Supply Disruption - Medicines
  • Primary Care Networks

Action category: Class 3: Action within 5 days

Title: CLASS 3 DRUG ALERT, ACTION WITHIN 5 DAYS, ACCORD HEALTHCARE LIMITED, AMLODIPINE 10MG TABLETS, PL 20075/0130

Broadcast content: Accord Healthcare Limited is recalling a specific batch of Amlodipine 10mg Tablets (batch number GY0128) as a precautionary measure due to out of specification results for tablet description, hardness and average weight obtained during stability testing.

Advice for healthcare professionals:
Stop supplying this batch immediately. Quarantine all stock from this batch and return it to your supplier using your supplier's approved process.

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts


Additional information: NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacies.
GP Practices: Please note this alert is for Dispensing GP Practices only.


Alert reference: EL (20)A/43

Attachments:
Cascade to:
  • #COMMUNITYPHARMACISTS#
  • #DISPENSING GP#
  • #HospitalPharmacy#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency